Results 91 to 100 of about 8,945 (197)

Rapid and inexpensive high-performance liquid chromatographic method for the quantification of flecainide in serum [PDF]

, 1988
H.M. Liebich, Mayer, F., Kühlkamp, V., K.M. Ress, Krämer, Bernhard K., F. Mayer, L. Seipel, Liebich, H. M., Seipel, L., B.K. Krämer, Ress, K. M., Becker, J. U., J.U. Becker, V. Kühlkamp, Risler, T., T. Risler   +15 more
core   +1 more source

Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?

, 1995
Objectives.This study compared the safety and efficacy of digoxin and flecainide in the prophylaxis of supraventricular tachycardia in infants.Background.Recurrence of supraventricular tachycardia in infants is common. Digoxin is the conventional drug of
Gardiner, Helena M., Christopher Wren, Wren, Christopher, Helena M. Gardiner, John J. O'Sullivan, O'Sullivan, John J.   +5 more
core   +1 more source

Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge

Clinical Case Reports, 2017
Key Clinical Message A negative flecainide challenge does not rule out Brugada syndrome even in the presence of nonfatal cardiac arrest as the first manifestation of the disease.
Samuel Chauveau, Olivier Le Vavasseur, Philippe Chevalier   +2 more
doaj   +1 more source

Flecainide and amiodarone: Combined therapy for refractory tachyarrhythmias in infancy

, 1995
Objectives.This study assessed the safety and efficacy of combined flecainide and amiodarone therapy in controlling refractory tachyarrhythmias in infants.Background.Single-drug as well as standard combination medical therapy for tachyarrhythmias in ...
James C. Perry, Richard A. Friedman, Arnold L. Fenrich, Fenrich, Arnold L., Perry, James C., Friedman, Richard A.   +5 more
core   +1 more source

Results of a Survey “Ethacizine evaluation for acute and chronic treatment of atrial fibrillation in real practice: Ukrainian national survey (ETERNITY)”

Сучасні медичні технології
The aim of the study: based on a survey of physicians, the study aims to identify the real clinical practices regarding the use of class IC antiarrhythmic drugs in Ukraine, particularly ethacizine, for restoring sinus rhythm in paroxysmal and persistent ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide

, 1991
The potential for proarrhythmic responses to the class IC sodium channel-blocking drugs encainide and flecainide has not been well described in young patients.
Benson, D.Woodrow, Gillette, Paul C, Fish, Frank A   +2 more
core   +1 more source

Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide

, 2014
Conflict of interestJT has received honoraria/consultancy fees from Menarini and Servier. JYLH has received consultancy fees and/or attended conferences and advisory boards for Astra-Zeneca, Bayer, BMS/Pfizer, Boehringer-Ingelheim, Correvio,Daiichi ...
Jean-Yves Le Heuzey, Juan Tamargo, Tamargo, Juan, Le Heuzey, Jean-Yves, Mabo, Phillipe, Phillipe Mabo   +5 more
core   +1 more source

Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias

Frontiers in Pharmacology
Flecainide acetate is a Class 1c anti-arrhythmic with a potent sodium voltage gated channel blockade which is utilized for the second-line treatment of tachyarrhythmias in children and adults.
Ronald Palmen, Mollie Walton, Mollie Walton, Mollie Walton, Jonathan Wagner, Jonathan Wagner, Jonathan Wagner   +6 more
doaj   +1 more source

Class IC Atrial Flutter Presenting as a Wide Complex Tachycardia: Lessons from a Case Report

Iberoamerican Journal of Medicine
Flecainide is an established antiarrhythmic agent for atrial fibrillation (AF), but monotherapy without atrioventricular nodal blockade can precipitate atrial flutter (AFL) with 1:1 conduction. This may result in a wide QRS complex tachycardia due to use-
Miguel Aurrecoechea-Perea, Hebert David Ayala-More, Isaac Vidal-Valdivia, Teresa Gonzalo-Moreno, María Gota-Nieto   +4 more
doaj   +1 more source

Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations

JACC: Advances
Background: Atrial fibrillation (AF) is associated with an increased risk of hospital admission, but few data on reasons for hospitalization and on the role of anti-arrhythmic drugs are available.
Danilo Menichelli, MD, Pasquale Pignatelli, MD, PhD, Tommaso Brogi, MD, Arianna Pannunzio, MD, Francesco Violi, MD, Gregory Y.H. Lip, MD, Daniele Pastori, MD, Tiziana Di Stefano, Elio Sabbatini, Patrizia Iannucci, Alberto Befani, Ilaria Maria Palumbo, Emanuele Valeriani   +12 more
doaj   +1 more source